Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1977 Feb;36(1):94–95. doi: 10.1136/ard.36.1.94

Dermatomyositis complicating penicillamine treatment.

L Fernandes, D R Swinson, E B Hamilton
PMCID: PMC1006640  PMID: 843119

Abstract

A case of dermatomyositis developing during the course of treatment with D-penicillamine in a patient with rheumatoid arthritis is described. Complete remission occurred on withdrawal of the drug. Possible alternative diagnoses are discussed.

Full text

PDF
94

Images in this article

95Image
on p.95

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bettendorf U., Neuhaus R. Penicillamin-induzierte Polymyositis. Dtsch Med Wochenschr. 1974 Dec 6;99(49):2513, 2522-5. [PubMed] [Google Scholar]
  2. Bucknall R. C., Dixon A St J., Glick E. N., Woodland J., Zutshi D. W. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. Br Med J. 1975 Mar 15;1(5958):600–602. doi: 10.1136/bmj.1.5958.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Camus J. P., Crouzet J., Guillien P., Benichou C., Lievre J. A. Cent cas de polyarthrite rhumatoïde commune traités par la D-pénicillamine. Ann Med Interne (Paris) 1974 Jan;125(1):9–28. [PubMed] [Google Scholar]
  4. Day A. T., Golding J. R. Hazards of penicillamine therapy in the treatment of rheumatoid arthritis. Postgrad Med J. 1974 Aug;50 (Suppl 2):71–73. [PubMed] [Google Scholar]
  5. Dubois E. L. Serologic abnormalities in spontaneous and drug-induced systemic lupus erythematosus. J Rheumatol. 1975 Jun;2(2):204–214. [PubMed] [Google Scholar]
  6. Goldenberg D. L., Stor R. A. Azathioprine hypersensitivity mimicking an acute exacerbation of dermatomyositis. J Rheumatol. 1975 Sep;2(3):346–349. [PubMed] [Google Scholar]
  7. Hughes G. R. Significance of anti-D.N.A. antibodies in systemic lupus erythematosus. Lancet. 1971 Oct 16;2(7729):861–863. doi: 10.1016/s0140-6736(71)90234-0. [DOI] [PubMed] [Google Scholar]
  8. Nishikai M., Funatsu Y., Homma M. Monoclonal gammopathy penicillamine-induced polymyositis and systemic sclerosis. Arch Dermatol. 1974 Aug;110(2):253–255. [PubMed] [Google Scholar]
  9. Pitkeathly D. A., Coomes E. N. Polymyositis in rheumatoid arthritis. Ann Rheum Dis. 1966 Mar;25(2):127–132. doi: 10.1136/ard.25.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schraeder P. L., Peters H. A., Dahl D. S. Polymyositis and penicillamine. Arch Neurol. 1972 Nov;27(5):456–457. doi: 10.1001/archneur.1972.00490170088013. [DOI] [PubMed] [Google Scholar]
  11. Walshe J. M. Toxic reactions to penicillamine in patients with Wilson's disease. Postgrad Med J. 1968 Oct;(Suppl):6–8. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES